Cargando…

Virulence factors in multidrug (MDR) and Pan-drug resistant (XDR) Pseudomonas aeruginosa: a cross-sectional study of isolates recovered from ocular infections in a high-incidence setting in southern India

BACKGROUND: Global concerns have been raised due to upward trend of Multi-drug Resistant (MDR) Pseudomonas aeruginosa reports in ocular infections. Our aim was to characterize the virulence determinants of MDR P. aeruginosa causing ocular infections. METHODS: P. aeruginosa strains were isolated from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naik, Poonam, Pandey, Suchita, Gagan, Satyashree, Biswas, Sudeshna, Joseph, Joveeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479063/ https://www.ncbi.nlm.nih.gov/pubmed/34585284 http://dx.doi.org/10.1186/s12348-021-00268-w

Ejemplares similares

Transcriptomic and Histological Analysis of Exacerbated Immune Response in Multidrug-Resistant Pseudomonas aeruginosa in a Murine Model of Endophthalmitis
por: Naik, Poonam, et al.
Publicado: (2022)

Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa
por: Kothari, Ashish, et al.
Publicado: (2023)

Multidrug-Resistant Pseudomonas aeruginosa Triggers Differential Inflammatory Response in Patients With Endophthalmitis
por: Naik, Poonam, et al.
Publicado: (2021)

MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017)

Multidrug-Resistant Pseudomonas aeruginosa Evokes Differential Inflammatory Responses in Human Microglial and Retinal Pigment Epithelial Cells
por: Naik, Poonam, et al.
Publicado: (2020)

Virulence factors and integrons are associated with MDR and XDR phenotypes in nosocomial strains of Pseudomonas aeruginosa in a Venezuelan university hospital
por: Rodulfo, Hectorina, et al.
Publicado: (2019)

1458. Uncharted territories: applying “precision medicine” to understand the treacherous landscape of extensively and multidrug resistant (XDR and MDR) Pseudomonas aeruginosa in a patient with cystic fibrosis and lung transplantation
por: Rojas, Laura J, et al.
Publicado: (2020)

XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?
por: Del Giacomo, Paola, et al.
Publicado: (2022)

2395. Mechanism-Based-Susceptibility Testing (MBST) Using Disc Diffusion Assays (DDA) to Guide Treatment of Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa (MDR-XDR-Pa) in a Cystic Fibrosis (CF) Lung Transplant Recipient; Are We Ready for Combination Therapy vs. MDR-XDR-Pa?
por: Abbo, Lilian M, et al.
Publicado: (2018)

Transmission of MDR and XDR Tuberculosis in Shanghai, China
por: Zhao, Ming, et al.
Publicado: (2009)

1063. ARGONAUT-V: Susceptibility of Multidrug-Resistant (MDR) Pseudomonas aeruginosa to Cefepime-Taniborbactam
por: Mack, Andrew R, et al.
Publicado: (2021)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)

Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs
por: Meschiari, Marianna, et al.
Publicado: (2021)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
por: Codecasa, Luigi R., et al.
Publicado: (2017)

223. Clinical Characteristics and Outcomes of Acinetobacter baumannii XDR and Pseudomonas aeruginosa XDR in a Tertiary Referral Medical Center in Mexico
por: Ojeda Yuren, Alicia Sarahi, et al.
Publicado: (2023)

Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran
por: Mirzaei, Bahman, et al.
Publicado: (2020)

The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2013)

The Burden of MDR/XDR Tuberculosis in Coastal Plains Population of China
por: Yang, Xiujun, et al.
Publicado: (2015)

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)

MDR and XDR typhoid fever-a threat for the current decade?
por: Pustake, Manas, et al.
Publicado: (2021)

Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa
por: Chavda, A, et al.
Publicado: (2021)

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks
por: Sirgel, Frederick A., et al.
Publicado: (2015)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
por: Zhang, Peize, et al.
Publicado: (2022)

Editorial: Current perspectives on Pseudomonas aeruginosa: epidemiology, virulence and contemporary strategies to combat multidrug-resistant (MDR) pathogens
por: Behzadi, Payam, et al.
Publicado: (2022)

Use of Ceftolozane-Tazobactam in Patient with Severe Medium Chronic Purulent Otitis by XDR Pseudomonas aeruginosa
por: Saraca, L. M., et al.
Publicado: (2019)

P44 Nosocomial neurosurgical meningitis due to XDR Pseudomonas aeruginosa: clinical experience with cefiderocol
por: Stevenson, D. R., et al.
Publicado: (2022)

atpD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and MDR-Proteus mirabilis
por: Algammal, Abdelazeem M., et al.
Publicado: (2021)

Emerging Trends of Multidrug-Resistant (MDR) and Extensively Drug-Resistant (XDR) Salmonella Typhi in a Tertiary Care Hospital of Lahore, Pakistan
por: Zakir, Muhammad, et al.
Publicado: (2021)

Multidrug-Resistant TB (MDR-TB) and Extensively Drug-Resistant TB (XDR-TB) Among Children: Where We Stand Now
por: Chowdhury, Kona, et al.
Publicado: (2023)

Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India
por: Balaji, V., et al.
Publicado: (2010)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
por: Busani, Stefano, et al.
Publicado: (2017)

P24 Cefiderocol activity against a multidrug-resistant (MDR) strain of Pseudomonas aeruginosa: a case report
por: Lim,, Felicia H., et al.
Publicado: (2022)

Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
por: Chan, Benjamin K., et al.
Publicado: (2016)

ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa
por: Puig-Collderram, Berta, et al.
Publicado: (2022)

Development and Evaluation of Bacteriophage Cocktail to Eradicate Biofilms Formed by an Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa
por: Vashisth, Medhavi, et al.
Publicado: (2023)

Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis
por: Agyeman, Akosua Adom, et al.
Publicado: (2016)

2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients with Multidrug-Resistant (MDR) Pseudomonas aeruginosa (PA) Infections
por: Hart, Delaney E, et al.
Publicado: (2019)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence
por: Garg, Suneel Kumar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_65cc5k2qso060cfqiecn73v1ll